Piper Jaffray analyst, Edward Tenthoff, reiterated an Overweight rating and $5.00 price target on AVEO Pharmaceuticals (NASDAQ: AVEO) after the ...

This is a premium only article. To continue reading this and other premium stock market news articles please sign-in or upgrade to StreetInsider.com Premium below (Free Trial) LEARN MORE